Defiance ETFs introduced the Defiance Daily Target 2X Long XOVR ETF (XOVL), offering 2x daily leveraged exposure to the ERShares Private-Public Crossover ETF (XOVR), which includes SpaceX and other entrepreneurial U.S. growth companies. This ETF targets active investors seeking amplified short-term gains through a blend of public and select late-stage private companies. The fund carries high risk due to leverage and is designed for daily trading, not long-term holding, with potential for significant losses. Investors should understand the complexities and risks, including volatility, liquidity, and the unique challenges of private company investments.
Silvaco and NVIDIA have teamed up to enhance semiconductor design and manufacturing by integrating NVIDIA's AI and accelerated computing with Silvaco's physics-based simulation technology. This collaboration aims to create high-fidelity digital twins...
Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, was ranked No. 3 on The Medicine Maker Power List 2026 in the Small Molecules category, recognizing his leadership in oncology drug development. Under his guidance, Ascentage Pharma has advanced i...
Ares Capital (ARCC) is recommended as a buy due to its reliable 10.13% dividend yield and disciplined distribution coverage. Since 2022, ARCC's cumulative profits and realized gains have exceeded its distributions by $1.05 billion, showing strong fin...
Hilton Worldwide Holdings was downgraded from 'buy' to 'hold' because of its elevated valuation and increasing net leverage, even though its asset-light strategy and loyalty program have driven strong revenue and profit growth. The company’s Q1 2026 ...
BYD, a leading new energy vehicle manufacturer, has partnered with Smart, Australia's top salary packaging and novated leasing provider, to make electric vehicles (EVs) more accessible and affordable for Australians. This partnership allows eligible ...
